William Grieco Sold 2,000 Shares of Acadia Healthcare Company (ACHC), Heska (HSKA) Had 2 Analysts Last Week

June 20, 2017 - By Nellie Frank

Among 4 analysts covering Heska Corp (NASDAQ:HSKA), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Heska Corp had 7 analyst reports since August 25, 2015 according to SRatingsIntel. Benchmark initiated the shares of HSKA in report on Tuesday, November 29 with “Buy” rating. On Thursday, August 4 the stock rating was downgraded by Gabelli to “Hold”. CL King initiated the shares of HSKA in report on Friday, April 1 with “Neutral” rating. CL King downgraded the shares of HSKA in report on Thursday, January 26 to “Neutral” rating. The firm has “Buy” rating by Benchmark given on Wednesday, March 1. The rating was upgraded by TheStreet on Tuesday, August 25 to “Hold”. See Heska Corp (NASDAQ:HSKA) latest ratings:

01/06/2017 Broker: Aegis Capital Rating: Buy New Target: $114.5 Initiates Coverage On
01/03/2017 Broker: Benchmark Rating: Buy Old Target: $100 New Target: $106 Maintain
26/01/2017 Broker: CL King Old Rating: Buy New Rating: Neutral Downgrade

The insider, and Acadia Healthcare Company Inc’s director, William Grieco, made a sale of 2,000 company shares on June 19, 2017, with market value of approximately $90,843 (at $45.4 of a share). Mr. William currently has rights to 46,013 shares, accounting for 0.05% of Acadia Healthcare Company Inc’s total market capitalization. The shares were unloaded on June 19, 2017 and the report that contains the source information, filed with the U.S. Security and Exchange Commission can be accessed here.

The stock increased 1.94% or $0.88 during the last trading session, reaching $46.14. About shares traded. Acadia Healthcare Company Inc (NASDAQ:ACHC) has declined 23.20% since June 20, 2016 and is downtrending. It has underperformed by 39.90% the S&P500.

Investors sentiment decreased to 1.05 in 2016 Q4. Its down 0.21, from 1.26 in 2016Q3. It dived, as 56 investors sold Acadia Healthcare Company Inc shares while 63 reduced holdings. 41 funds opened positions while 84 raised stakes. 98.86 million shares or 8.20% more from 91.37 million shares in 2016Q3 were reported. Pembroke Mgmt owns 406,845 shares. Bnp Paribas Arbitrage holds 0% or 1,081 shares in its portfolio. 40,000 are owned by Shanda Asset Mngmt Holdings. Penn Capital Incorporated holds 1.23M shares. Massachusetts-based Eagle Boston Invest Mngmt has invested 0.25% in Acadia Healthcare Company Inc (NASDAQ:ACHC). Gru One Trading Limited Partnership reported 0% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC). Century Cap Mgmt Limited Liability Corp accumulated 0.57% or 131,876 shares. King Luther Management accumulated 25,180 shares. Broadview Advsrs Ltd has invested 0.45% in Acadia Healthcare Company Inc (NASDAQ:ACHC). California State Teachers Retirement System reported 0.01% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC). Moreover, Jefferies Ltd Liability has 0.06% invested in Acadia Healthcare Company Inc (NASDAQ:ACHC) for 341,369 shares. Consonance Cap Mngmt Lp has 1.86% invested in Acadia Healthcare Company Inc (NASDAQ:ACHC) for 510,666 shares. Segall Bryant And Hamill Ltd Llc holds 0.02% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC) for 21,787 shares. Citigroup Incorporated has 0% invested in Acadia Healthcare Company Inc (NASDAQ:ACHC). Verition Fund Management Lc invested 0.05% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC).

Among 14 analysts covering Acadia Healthcare (NASDAQ:ACHC), 12 have Buy rating, 0 Sell and 2 Hold. Therefore 86% are positive. Acadia Healthcare has $100 highest and $4 lowest target. $62.54’s average target is 35.54% above currents $46.14 stock price. Acadia Healthcare had 26 analyst reports since August 6, 2015 according to SRatingsIntel. The company was upgraded on Thursday, August 6 by Zacks. The firm earned “Buy” rating on Wednesday, January 4 by Citigroup. The company was maintained on Thursday, August 6 by Mizuho. The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) earned “Neutral” rating by JP Morgan on Wednesday, September 16. The stock has “Strong Buy” rating by Raymond James on Thursday, November 3. As per Monday, February 27, the company rating was maintained by Mizuho. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, October 19. The firm earned “Neutral” rating on Friday, January 27 by Cantor Fitzgerald. KeyBanc Capital Markets initiated the stock with “Overweight” rating in Monday, February 1 report. Leerink Swann initiated the shares of ACHC in report on Tuesday, September 1 with “Outperform” rating.

Analysts await Acadia Healthcare Company Inc (NASDAQ:ACHC) to report earnings on August, 4. They expect $0.65 EPS, down 10.96% or $0.08 from last year’s $0.73 per share. ACHC’s profit will be $56.21M for 17.75 P/E if the $0.65 EPS becomes a reality. After $0.46 actual EPS reported by Acadia Healthcare Company Inc for the previous quarter, Wall Street now forecasts 41.30% EPS growth.

Since March 2, 2017, it had 0 insider purchases, and 9 sales for $163.69 million activity. Shares for $33.00 million were sold by WAUD REEVE B on Wednesday, June 14. Fincher Ronald Morgan sold $3.84 million worth of Acadia Healthcare Company Inc (NASDAQ:ACHC) on Monday, May 1. 914 shares were sold by GOLDBERG RANDALL P, worth $39,802. Schwieger Scott also sold $44,194 worth of Acadia Healthcare Company Inc (NASDAQ:ACHC) shares. 1,000 shares were sold by GRIECO WILLIAM, worth $42,560 on Friday, March 10.

Acadia Healthcare Company, Inc. is a well-known provider of behavioral healthcare services, with activities in the United States and the United Kingdom. The company has market cap of $3.99 billion. The Firm focuses on acquiring and developing behavioral healthcare facilities. It has a 313.22 P/E ratio. The Firm operates through two divisions: U.S.

Investors sentiment decreased to 0.84 in Q4 2016. Its down 0.52, from 1.36 in 2016Q3. It dropped, as 7 investors sold Heska Corp shares while 49 reduced holdings. 19 funds opened positions while 28 raised stakes. 4.92 million shares or 2.58% more from 4.80 million shares in 2016Q3 were reported. Dupont Cap Mgmt owns 8,083 shares. New York-based State Common Retirement Fund has invested 0% in Heska Corp (NASDAQ:HSKA). Neuberger Berman Group Inc Limited Liability Corp reported 0.03% in Heska Corp (NASDAQ:HSKA). Gamco Investors Inc Et Al invested in 0.02% or 45,700 shares. Driehaus Cap Mgmt Limited Liability Corporation reported 105,232 shares stake. Deutsche Bank & Trust Ag has invested 0% in Heska Corp (NASDAQ:HSKA). Timpani Cap Management Lc invested in 2.61% or 87,437 shares. Clarivest Asset Mngmt stated it has 0.03% in Heska Corp (NASDAQ:HSKA). Eam Invsts Limited Company reported 101,441 shares. Citigroup Inc owns 7,426 shares. Legal General Group Incorporated Public Ltd Liability Co owns 0% invested in Heska Corp (NASDAQ:HSKA) for 1,618 shares. Blackrock has 0% invested in Heska Corp (NASDAQ:HSKA) for 3,717 shares. Financial Bank Of New York Mellon Corp holds 156,321 shares. Panagora Asset Mngmt Incorporated has 0.02% invested in Heska Corp (NASDAQ:HSKA) for 46,097 shares. Credit Suisse Ag accumulated 334,806 shares.

Heska Corporation sells veterinary diagnostic and specialty products. The company has market cap of $650.89 million. The Firm operates through two divisions: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products (OVP). It has a 50.43 P/E ratio. The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: